“…One of the reasons for the hampered prognostic and predictive potential of these assays might be the fact that they are based on signatures that have been constructed from whole tumor tissue, which includes all tumor and stromal cells, instead of just the subpopulations of metastasizing tumor cells. To reveal the mechanisms responsible for the metastatic phenotype, gene expression has been performed on disseminating tumor cells, either circulating tumor cells (CTCs) (De Mattos-Arruda et al, 2013), or migratory-disseminating tumor cells isolated from the primary tumor Hernandez et al, 2009;Patsialou et al, 2013Patsialou et al, , 2012Philippar et al, 2008;Roussos et al, 2011a,b,c;Wang et al, 2004Wang et al, , 2005Wang et al, , 2006Wang et al, , 2003Wyckoff et al, 2011Wyckoff et al, , 2000 (see poster). These signatures provide additional insights into the biological processes that are employed during metastasis, such as epithelial-tomesenchymal transition (EMT), invasion and migration, resistance to apoptosis and anoikis, and intravasation.…”